Durvalumab for Stage III EGFR-Mutated NSCLC After Definitive Chemoradiotherapy
| Autor: | Aredo, Jacqueline V., Mambetsariev, Isa, Hellyer, Jessica A., Amini, Arya, Neal, Joel W., Padda, Sukhmani K., McCoach, Caroline E., Riess, Jonathan W., Cabebe, Elwyn C., Naidoo, Jarushka, Abuali, Tariq, Salgia, Ravi, Loo, Billy W., Jr., Diehn, Maximilian, Han, Summer S., Wakelee, Heather A. |
|---|---|
| Zdroj: | In Journal of Thoracic Oncology June 2021 16(6):1030-1041 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|